AAPS PharmSciTech

, Volume 19, Issue 7, pp 3110–3122 | Cite as

Strategic Pentablock Copolymer Nanomicellar Formulation for Paclitaxel Delivery System

  • Alex Oselu Owiti
  • Ashim MitraEmail author
  • Mary Joseph
  • Dhananjay Pal
Research Article


Nanomicelles (NM) enhance solubility and absorption of active pharmaceutical ingredients (APIs). Various polymers and non-polymers are utilized to prepare nanomicellar formulations to achieve high absorption and delivery of drugs. The main purpose of this study was to develop drug-loaded nanomicelles with pentablock copolymers for paclitaxel delivery. Monomers of lactide, ε-caprolactone, and polyethylene-glycol were utilized to prepare pentablock copolymer by ring opening technique. The pentablock nanomicelles (PBNM) were formulated by evaporation and rehydration. Both copolymers and nanomicelles were analyzed by H-NMR, FTIR, and XRD. Nanomicelles were further analyzed for size and zeta potential using dynamic light scattering (DLS) and by H-NMR and TEM. The XRD, FTIR, and H-NMR analyses confirmed the structures of the pentablock copolymers. Average size was 20 nm ± 5.00 nm, and ζ-potential is around zero. H-NMR and FTIR analyses for Paclitaxel-PBNM indicated peaks of paclitaxel and the polymer, confirming successful encapsulation. TEM showed spherical morphology and size range similar to that obtained by DLS. In vitro release studies revealed slow first-order paclitaxel release rate from pentablock nanomicelles in phosphate buffer solution (PBS). Confocal laser scanning microscopy analysis with coumarin-6-loaded in PBNM indicated that pentablock nanomicelles were efficiently taken into prostate cancer (PC-3) cells. Cell proliferation assay showed that nanomicelles were able to ferry adequate amounts of paclitaxel drug into PC-3 cells and subsequently inhibiting PC-3 cell proliferation significantly. Results confirmed that pentablock copolymer can generate drug-loaded nanomicelles with desirable sizes and zeta potential. These demonstrate potentiality of pentablock nanomicelles as carrier for anticancer delivery.


pentablock copolymers prostate cancer paclitaxel delivery nanomicellar formulation coumarin-6 



The authors wish to express their most sincere gratitude to the following: (1) CAPES Foundation, Ministry of Education of Brazil, Brasília—DF 70040-020, Brazil, for funding through SwB scholarship, (2) Ms. Barbara Fegley of the University of Kansas Medical Center for TEM facility, and (3) Mrs. Abrar Alnafisah for FTIR facility.


  1. 1.
    Singla AK, Garg A, Aggarwal D. Paclitaxel and its formulations. Int J Pharm. 2002;235(1–2):179–92.CrossRefGoogle Scholar
  2. 2.
    Zhou J, Zhao WY, Ma X, Ju RJ, Li XY, Li N, et al. The anticancer efficacy of paclitaxel liposomes modified with mitochondrial targeting conjugate in resistant lung cancer. Biomaterials. 2013;34(14):3626–38.CrossRefGoogle Scholar
  3. 3.
    He Y, Liang S, Long M, Xu H. Mesoporous silica nanoparticles as potential carriers for enhanced drug solubility of paclitaxel. Mater Sci Eng C Mater Biol Appl. 2017;78:12–7.CrossRefGoogle Scholar
  4. 4.
    Zhou Y, Wen H, Gu L, Fu J, Guo J, Du L, et al. Aminoglucose-functionalized, redox-responsive polymer nanomicelles for overcoming chemoresistance in lung cancer cells. J Nanobiotechnol. 2017;15(1):87.CrossRefGoogle Scholar
  5. 5.
    Creel CJ, Lovich MA, Edelman ER. Arterial paclitaxel distribution and deposition. Circ Res. 2000;86(8):879–84.CrossRefGoogle Scholar
  6. 6.
    Vadlapudi AD, Cholkar K, Vadlapatla RK, Mitra AK. Aqueous nanomicellar formulation for topical delivery of biotinylated lipid prodrug of acyclovir: formulation development and ocular biocompatibility. J Ocul Pharmacol Ther. 2014;30(1):49–58.CrossRefPubMedPubMedCentralGoogle Scholar
  7. 7.
    Vaishya RD, Khurana V, Patel S, Mitra AK. Controlled ocular drug delivery with nanomicelles. Wiley Interdiscip Rev Nanomed Nanobiotechnol. 2014;6(5):422–37.CrossRefPubMedPubMedCentralGoogle Scholar
  8. 8.
    Yang X, Trinh HM, Agrahari V, Sheng Y, Pal D, Mitra AK. Nanoparticle-based topical ophthalmic gel formulation for sustained release of hydrocortisone butyrate. AAPS PharmSciTech. 2016;17(2):294–306.CrossRefGoogle Scholar
  9. 9.
    Bohidar HB, Behboudnia M. Characterization of reverse micelles by dynamic light scattering. Colloids Surf. 2001;178:313–23.CrossRefGoogle Scholar
  10. 10.
    Patel SP, Vaishya R, Pal D, Mitra AK. Novel pentablock copolymer-based nanoparticulate systems for sustained protein delivery. AAPS PharmSciTech. 2015;16(2):327–43.CrossRefGoogle Scholar
  11. 11.
    Rizvi SA, Shamsi SA. Polymeric alkenoxy amino acid surfactants: I. Highly selective class of molecular micelles for chiral separation of beta-blockers. Electrophoresis. 2003;24(15):2514–26.CrossRefGoogle Scholar
  12. 12.
    Pool R, Bolhuis PG. Accurate free energies of micelle formation. J Phys Chem B. 2005;109(14):6650–7.CrossRefGoogle Scholar
  13. 13.
    Tamboli V, Mishra GP, Mitra AK. Novel pentablock copolymer (PLA-PCL-PEG-PCL-PLA) based nanoparticles for controlled drug delivery: effect of copolymer compositions on the crystallinity of copolymers and in vitro drug release profile from nanoparticles. Colloid Polym Sci. 2013;291(5):1235–45.CrossRefGoogle Scholar
  14. 14.
    Cholkar K, Patel A, Vadlapudi AD, Mitra AK. Novel Nanomicellar formulation approaches for anterior and posterior segment ocular drug delivery. Recent Pat Nanomedicine. 2012;2(2):82–95.CrossRefGoogle Scholar
  15. 15.
    Agrahari V, Agrahari V, Mandal A, Pal D, Mitra AK. How are we improving the delivery to back of the eye? Advances and challenges of novel therapeutic approaches. Expert Opin Drug Deliv. 2017;14(10):1145–62.CrossRefGoogle Scholar
  16. 16.
    Patel SP, Vaishya R, Mishra GP, Tamboli V, Pal D, Mitra AK. Tailor-made pentablock copolymer based formulation for sustained ocular delivery of protein therapeutics. J Drug Deliv. 2014;2014:401747.CrossRefPubMedPubMedCentralGoogle Scholar
  17. 17.
    Bobbala S, Tamboli V, McDowell A, Mitra AK, Hook S. Novel injectable Pentablock copolymer based thermoresponsive hydrogels for sustained release vaccines. AAPS J. 2016;18(1):261–9.CrossRefGoogle Scholar
  18. 18.
    Vaishya RD, Gokulgandhi M, Patel S, Minocha M, Mitra AK. Novel dexamethasone-loaded nanomicelles for the intermediate and posterior segment uveitis. AAPS PharmSciTech. 2014;15(5):1238–51.CrossRefPubMedPubMedCentralGoogle Scholar
  19. 19.
    Youm I, Agrahari V, Murowchick JB, Youan BB. Uptake and cytotoxicity of docetaxel-loaded hyaluronic acid-grafted oily core nanocapsules in MDA-MB 231 cancer cells. Pharm Res. 2014;31(9):2439–52.CrossRefGoogle Scholar
  20. 20.
    Wei Z, Hao J, Yuan S, Li Y, Juan W, Sha X, et al. Paclitaxel-loaded Pluronic P123/F127 mixed polymeric micelles: formulation, optimization and in vitro characterization. Int J Pharm. 2009;376(1–2):176–85.CrossRefGoogle Scholar
  21. 21.
    Xia D, Lai DV, Wu W, Webb ZD, Yang Q, Zhao L, et al. Transition from androgenic to neurosteroidal action of 5α- androstane-3α, 17β-diol through the type A γ-aminobutyric acid receptor in prostate cancer progression. J Steroid Biochem Mol Biol. 2017;178:89–98.Google Scholar
  22. 22.
    Abdelwahed W, Degobert G, Stainmesse S, Fessi H. Freeze-drying of nanoparticles: formulation, process and storage considerations. Adv Drug Deliv Rev. 2006;58(15):1688–713.CrossRefGoogle Scholar
  23. 23.
    Youm I, Yang XY, Murowchick JB, Youan BB. Encapsulation of docetaxel in oily core polyester nanocapsules intended for breast cancer therapy. Nanoscale Res Lett. 2011;6(1):630.CrossRefPubMedPubMedCentralGoogle Scholar
  24. 24.
    Youm I, Murowchick JB, Youan BB. Entrapment and release kinetics of furosemide from pegylated nanocarriers. Colloids Surf B Biointerfaces. 2012;94:133–42.CrossRefGoogle Scholar
  25. 25.
    Youm I, Youan BB. Uptake mechanism of furosemide-loaded pegylated nanoparticles by cochlear cell lines. Hear Res. 2013;304:7–19.CrossRefGoogle Scholar
  26. 26.
    Patel SP, Vaishya R, Yang X, Pal D, Mitra AK. Novel thermosensitive pentablock copolymers for sustained delivery of proteins in the treatment of posterior segment diseases. Protein Pept Lett. 2014;21(11):1185–200.CrossRefPubMedPubMedCentralGoogle Scholar
  27. 27.
    Patel SP, Vaishya R, Patel A, Agrahari V, Pal D, Mitra AK. Optimization of novel pentablock copolymer based composite formulation for sustained delivery of peptide/protein in the treatment of ocular diseases. J Microencapsul. 2016;33(2):103–13.CrossRefPubMedPubMedCentralGoogle Scholar
  28. 28.
    Agrahari V, Li G, Agrahari V, Navarro I, Perkumas K, Mandal A, et al. Pentablock copolymer dexamethasone nanoformulations elevate MYOC: in vitro liberation, activity and safety in human trabecular meshwork cells. Nanomedicine. 2017;12(16):1911–26.CrossRefPubMedPubMedCentralGoogle Scholar
  29. 29.
    Agrahari V, Agrahari V, Mitra AK. Nanocarrier fabrication and macromolecule drug delivery: challenges and opportunities. Ther Deliv. 2016;7(4):257–78.CrossRefPubMedPubMedCentralGoogle Scholar
  30. 30.
    Sawdon AJ, Peng CA. Polymeric micelles for acyclovir drug delivery. Colloids Surf B Biointerfaces. 2014;122:738–45.CrossRefPubMedPubMedCentralGoogle Scholar
  31. 31.
    Lian H, He Z, Meng Z. Rational design of hybrid nanomicelles integrating mucosal penetration and P-glycoprotein inhibition for efficient oral delivery of paclitaxel. Colloids Surf B Biointerfaces. 2017;155:429–39.CrossRefGoogle Scholar
  32. 32.
    Jones LJ, Gray M, Yue ST, Haugland RP, Singer VL. Sensitive determination of cell number using the CyQUANT (R) cell proliferation assay. J Immunol Methods. 2001;254(1–2):85–98.CrossRefGoogle Scholar
  33. 33.
    Hoque ME, Hutmacher DW, Feng W, Li S, Huang MH, Vert M, et al. Fabrication using a rapid prototyping system and in vitro characterization of PEG-PCL-PLA scaffolds for tissue engineering. J Biomater Sci Polym Ed. 2005;16(12):1595–610.CrossRefGoogle Scholar
  34. 34.
    Bosca S, Barresi AA, Fissore D. Fast freeze-drying cycle design and optimization using a PAT based on the measurement of product temperature. Eur J Pharm Biopharm. 2013;85(2):253–62.CrossRefGoogle Scholar
  35. 35.
    Abdelwahed W, Degobert G, Fessi H. Investigation of nanocapsules stabilization by amorphous excipients during freeze-drying and storage. Eur J Pharm Biopharm. 2006;63(2):87–94.CrossRefGoogle Scholar
  36. 36.
    Abdelwahed W, Degobert G, Fessi H. A pilot study of freeze drying of poly(epsilon-caprolactone) nanocapsules stabilized by poly(vinyl alcohol): formulation and process optimization. Int J Pharm. 2006;309(1–2):178–88.CrossRefGoogle Scholar
  37. 37.
    Cholkar K, Gunda S, Earla R, Pal D, Mitra AK. Nanomicellar topical aqueous drop formulation of rapamycin for back-of-the-eye delivery. AAPS PharmSciTech. 2015;16(3):610–22.CrossRefGoogle Scholar
  38. 38.
    Fernandes HP, Cesar CL, Barjas-Castro ML. Electrical properties of the red blood cell membrane and immunohematological investigation. Rev Bras Hematol Hemoter. 2011;33(4):297–301.CrossRefPubMedPubMedCentralGoogle Scholar
  39. 39.
    Yashwant Pathak DT. Drug delivery nanoparticles formulation and characterization. In: Yashwant P DT, editor. 191; 2009. p. 80–3.Google Scholar
  40. 40.
    Yoo HS, Park TG. Biodegradable polymeric micelles composed of doxorubicin conjugated PLGA-PEG block copolymer. J Control Release. 2001;70(1–2):63–70.CrossRefGoogle Scholar

Copyright information

© American Association of Pharmaceutical Scientists 2018

Authors and Affiliations

  • Alex Oselu Owiti
    • 1
  • Ashim Mitra
    • 1
    Email author
  • Mary Joseph
    • 1
  • Dhananjay Pal
    • 1
  1. 1.University of Missouri-Kansas CityKansas CityUSA

Personalised recommendations